share_log

Tsaker Chemical Group Limited (HKG:1986) Held Back By Insufficient Growth Even After Shares Climb 35%

Tsaker Chemical Group Limited (HKG:1986) Held Back By Insufficient Growth Even After Shares Climb 35%

扎克化工集團有限公司(HKG:1986)在股價上漲35%後仍因增長不足而停滯不前
Simply Wall St ·  2022/06/22 18:27

The Tsaker Chemical Group Limited (HKG:1986) share price has done very well over the last month, posting an excellent gain of 35%. The last 30 days bring the annual gain to a very sharp 35%.

這個扎克化工集團有限公司(HKG:1986)股價在過去一個月中表現非常好,錄得35%的出色漲幅。在過去的30天裏,年度漲幅達到了非常大的35%。

In spite of the firm bounce in price, given close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 10x, you may still consider Tsaker Chemical Group as an attractive investment with its 6.5x P/E ratio. However, the P/E might be low for a reason and it requires further investigation to determine if it's justified.

儘管股價強勁反彈,但鑑於近一半的香港公司的市盈率(或“市盈率”)高於10倍,你可能仍會認為察克化工集團的6.5倍市盈率是一個有吸引力的投資對象。然而,市盈率可能是有原因的,需要進一步調查才能確定它是否合理。

Recent times have been quite advantageous for Tsaker Chemical Group as its earnings have been rising very briskly. One possibility is that the P/E is low because investors think this strong earnings growth might actually underperform the broader market in the near future. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.

最近對Tsaker化學集團來説是相當有利的,因為它的收益一直在快速增長。一種可能性是,市盈率較低,因為投資者認為,這種強勁的收益增長在不久的將來實際上可能會遜於大盤。如果你喜歡這家公司,你會希望情況並非如此,這樣你就可以在它不再受青睞的時候買入一些股票。

View our latest analysis for Tsaker Chemical Group

查看我們對Tsaker化工集團的最新分析

SEHK:1986 Price Based on Past Earnings June 22nd 2022 Although there are no analyst estimates available for Tsaker Chemical Group, take a look at this
聯交所:1986年價格基於過去收益2022年6月22日儘管沒有分析師對扎克化工集團的估計,但請看一下這一點
free
免費
data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.
豐富的數據可視化,看看公司的收益、收入和現金流是如何堆積的。

Is There Any Growth For Tsaker Chemical Group?

Tsaker化工集團有增長嗎?

In order to justify its P/E ratio, Tsaker Chemical Group would need to produce sluggish growth that's trailing the market.

為了證明其市盈率是合理的,Tsaker化學集團需要實現落後於市場的低迷增長。

If we review the last year of earnings growth, the company posted a terrific increase of 57%. Still, EPS has barely risen at all from three years ago in total, which is not ideal. So it appears to us that the company has had a mixed result in terms of growing earnings over that time.

如果我們回顧過去一年的收益增長,該公司公佈了57%的驚人增長。儘管如此,與三年前相比,每股收益總體上幾乎沒有上升,這並不理想。因此,在我們看來,在這段時間裏,該公司在收益增長方面的結果好壞參半。

Comparing that to the market, which is predicted to deliver 16% growth in the next 12 months, the company's momentum is weaker based on recent medium-term annualised earnings results.

與預計未來12個月將實現16%增長的市場相比,根據最近的中期年化收益結果,該公司的增長勢頭較弱。

With this information, we can see why Tsaker Chemical Group is trading at a P/E lower than the market. It seems most investors are expecting to see the recent limited growth rates continue into the future and are only willing to pay a reduced amount for the stock.

有了這些信息,我們就可以理解為什麼Tsaker化學集團的市盈率低於市場。似乎大多數投資者都預計,最近有限的增長率將持續到未來,他們只願意為該股支付較低的價格。

The Final Word

最後的結論

The latest share price surge wasn't enough to lift Tsaker Chemical Group's P/E close to the market median. While the price-to-earnings ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of earnings expectations.

最新的股價飆升不足以將Tsaker Chemical Group的市盈率推高至接近市場中值的水平。雖然市盈率不應該是你是否買入一隻股票的決定性因素,但它是一個很好的盈利預期晴雨表。

As we suspected, our examination of Tsaker Chemical Group revealed its three-year earnings trends are contributing to its low P/E, given they look worse than current market expectations. At this stage investors feel the potential for an improvement in earnings isn't great enough to justify a higher P/E ratio. Unless the recent medium-term conditions improve, they will continue to form a barrier for the share price around these levels.

正如我們懷疑的那樣,我們對Tsaker化學集團的審查顯示,其三年盈利趨勢是導致其低市盈率的原因之一,因為它們看起來比目前的市場預期更糟糕。在這個階段,投資者認為盈利改善的潛力還不夠大,不足以證明提高市盈率是合理的。除非近期的中期狀況有所改善,否則將繼續在這些水平附近形成股價障礙。

Before you take the next step, you should know about the 2 warning signs for Tsaker Chemical Group that we have uncovered.

在您採取下一步之前,您應該瞭解Tsaker化工集團的2個警告標誌我們已經發現了。

You might be able to find a better investment than Tsaker Chemical Group. If you want a selection of possible candidates, check out this free list of interesting companies that trade on a P/E below 20x (but have proven they can grow earnings).

你也許能找到比Tsaker化學集團更好的投資。如果您想要選擇可能的候選人,請查看以下內容免費令人感興趣的市盈率低於20倍的公司名單(但已證明它們可以增加收益)。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論